Comparative effects of anti-thymocyte globulin (ATGAM) vs interleukin-2receptor monoclonal antibody based induction therapy on cadaveric renal transplant outcome

被引：0
|
作者：
Lal, Sunder M. [1 ]
Gupta, Nilakshi [1 ]
Ross Jr., Gilbert [1 ]
机构：
[1] Univ of Missouri Health Science Cent, Columbia, United States
来源：
ASAIO Journal | 2000年 / 46卷 / 02期
关键词：
D O I：
10.1097/00002480-200003000-00285
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Long-term evolution of lymphocytes subsets after induction therapy based on continuous versus discontinuous administration of anti-thymocyte globulins in renal-transplant patients
    Esposito, L
    Kamar, N
    Tkaczuk, J
    Abbal, M
    Durand, D
    Rostaing, L
    TRANSPLANTATION PROCEEDINGS, 2005, 37 (02) : 785 - 787
  • [42] Rabbit anti-thymocyte globulin (rATG) versus IL-2 receptor antagonist induction therapies in tacrolimus-based immunosuppression era: a meta-analysis
    Ali, Hatem
    Soliman, Karim M.
    Shaheen, Ihab
    Kim, Jon Jin
    El Kossi, Mohsen
    Sharma, Ajay
    Pararajasingam, Ravi
    Halawa, Ahmed
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2020, 52 (04) : 791 - 802
  • [43] Implication of interleukin-2 receptor antibody induction therapy in standard risk renal transplant in the tacrolimus era: a meta-analysis
    Ali, Hatem
    Mohiuddin, Atif
    Sharma, Ajay
    Shaheen, Ihab
    Kim, Jon Jin
    El Kosi, Mohsen
    Halawa, Ahmed
    CLINICAL KIDNEY JOURNAL, 2019, 12 (04) : 592 - 599
  • [44] INTERLEUKIN-2 RECEPTOR ANTIBODY INDUCTION THERAPY IN STANDARD-RISK RENAL TRANSPLANT IN TACROLIMUS ERA: UK REGISTRY DATA
    Ali, Hatem
    Ajay, Sharma
    Shaheen, Ihab
    Kim, Jon Jin
    Elkossi, Mohsen
    Pararajasingam, Ravi
    Ahmed, Gen
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34
  • [45] LOW PREVALENCE OF POST-TRANSPLANT ANTI-HLA CLASS 2 ANTIBODIES IN LIVING DONOR KIDNEY RECIPIENTS TREATED WITH ANTI-THYMOCYTE GLOBULIN (ATG) INDUCTION THERAPY-SINGLE CENTER EXPIRIANCE
    Severova-Andreevska, Galina
    Trajceska, Lada
    Danilovska, Ilina
    Sikole, Aleksandar
    Popov, Zivko
    Ivanovski, Ninoslav
    TRANSPLANT INTERNATIONAL, 2015, 28 : 210 - 210
  • [46] Antithymocyte Globulin (ATG) versus Anti-interleukin-2 Receptor (Anti-IL-2R) as Induction Therapy for Kidney Transplantation After a Nonrenal Transplant.
    Mai, H.
    Trebern-Launay, K.
    Legendre, C.
    Kessler, M.
    Rostaing, L.
    Garrigue, V.
    Morelon, E.
    Brouard, S.
    Giral, M.
    Soulillou, J. -P.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 386 - 386
  • [47] Immunoprophylaxis with basiliximab, a chimeric anti-interleukin-2 receptor monoclonal antibody, in combination with azathioprine-containing triple therapy in liver transplant recipients
    Calmus, Y
    Scheele, JR
    Gonzalez-Pinto, I
    Jaurrieta, EJ
    Klar, E
    Pageaux, GP
    Scudamore, CH
    Cuervas-Mons, V
    Metselaar, HJ
    Prestele, H
    Girault, D
    LIVER TRANSPLANTATION, 2002, 8 (02) : 123 - 131
  • [48] Long-term results of monoclonal anti-II2-receptor antibody versus polyclonal antilymphocyte antibodies as induction therapy in renal transplantation
    Al Najjar, A.
    Etienne, I.
    Le Pogamp, P.
    Bridoux, F.
    Le Meur, Y.
    Toupance, O.
    Mousson, C.
    Caillard, S.
    de Ligny, B. Hurault
    Marliere, J. F.
    Lebranchu, Y.
    TRANSPLANTATION PROCEEDINGS, 2006, 38 (07) : 2298 - 2299
  • [49] A randomised, double-blind, placebo controlled trial of anti interleukin-2 receptor monoclonal antibody (daclizumab) induction therapy after heart transplantation.
    van Gelder, T
    Wabbijn, M
    van Domburg, R
    Vantrimpont, P
    Maat, L
    Baan, C
    Weimar, W
    Balk, A
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 282 - 282
  • [50] Haploidentical donor bone marrow transplantation (BMT) for advanced hematologic malignancy (HM) following non-myeloablative preparative therapy: Role of in vivo T-cell depletion with anti-thymocyte globulin or anti-CD2 monoclonal antibody therapy (MEDI-507).
    Spitzer, TR
    McAfee, S
    Sackstein, R
    Dey, B
    Colby, C
    Grossberg, H
    Hope, J
    Saidman, S
    Preffer, F
    Alexander, S
    Sachs, DH
    Sykes, M
    BLOOD, 2000, 96 (11) : 841A - 841A
12345